WASHINGTON — First Lady Melania Trump on Monday unveiled one of the most expansive policy efforts of her tenure, signing an executive order aimed at reshaping women’s health research and accelerating medical innovation. The initiative, announced at the National Institutes of Health and supported by a newly formed White House Women’s Health Task Force, marks a significant expansion of the First Lady’s public service portfolio during President Donald Trump’s second term. Women's healthcare advancement is also a feature of her predecessor Dr. Jill Biden's legacy.
The executive order, titled Advancing Women’s Health to Improve Outcomes in All Phases of Life, directs federal agencies to prioritize research into diseases that uniquely or disproportionately affect women. It also calls for increased collaboration with private‑sector partners to develop new technologies, treatments and diagnostic tools.
The First Lady said the United States is entering “a transformative moment for women in America,” citing advances in biotechnology, artificial intelligence and medical science that she believes can dramatically improve health outcomes.
“Previous generations fought for women’s rights,” Trump said in prepared remarks. “Our generation will fight to discover the cures that will ensure a woman can live her life in health and to the fullest.”
A Growing Policy Portfolio
Since returning to the White House, Trump has broadened her public initiatives under the umbrella of her Be Best program, which originally focused on children’s well‑being and internet safety. Over the past two years, she has added efforts supporting military families, promoting responsible AI innovation and encouraging digital literacy among youth.
The women’s health initiative is her most sweeping policy effort to date. The executive order establishes a national framework for research and development, including the use of “super intelligence” — a term the administration uses to describe advanced computational tools — to deepen scientific understanding of female biology.
Five Pillars of Women’s Health Innovation
Trump outlined what she called the First Lady’s Five Pillars of Women’s Health Innovation, which will guide the task force’s work:
Direct research funding toward cures for diseases that affect women in unique ways. The administration says many conditions — including autoimmune disorders, reproductive cancers and chronic pain syndromes — remain under‑researched despite disproportionately affecting women.
Use advanced intelligence systems to enhance insight into female biology and accelerate medical discoveries. Trump said emerging technologies can shorten the timeline for identifying disease mechanisms and developing targeted therapies.
Speed the transition of promising treatments from laboratories to patients while maintaining strict safety standards. The First Lady emphasized the need to reduce regulatory bottlenecks without compromising patient protections.
Ensure breakthroughs are accessible and affordable to women regardless of income. “Medical advances should serve every woman,” she said, noting disparities in access to care.
Replace generations of silence with open conversation, education and compassion. Trump said cultural stigma has long prevented women from discussing health concerns openly, hindering early diagnosis and treatment.
“Our mission must serve women at every stage of life,” she said. “From young girls just starting out, to mothers balancing complex responsibilities, to mature women who deserve vitality, dignity and independence.”
A Call for Collaboration
The executive order highlights the role of private‑sector innovation in advancing women’s health. Administration officials say partnerships with biotech firms, research institutions and pharmaceutical companies will be essential to developing new therapies and expanding clinical trials.
The First Lady said the first working session of the Women’s Health Task Force would convene Monday afternoon, bringing together Cabinet members, researchers, clinicians and federal administrators.
“We will move our hopes into action,” she said. “Beginning today, we will change the reality of women’s health.”
How Jill Biden’s Initiative Worked — and How Melania Trump’s Effort Compares
Dr. Biden launched the White House Initiative on Women’s Health Research in November 2023 with a goal to fundamentally change how the United States approaches and funds women’s health research. The initiative, led jointly by the Office of the First Lady and the White House Gender Policy Council, was designed to close long‑standing gaps in medical research by prioritizing conditions that uniquely affect women, disproportionately impact them, or present differently in women than in men. The Biden initiative emphasized correcting decades of underrepresentation of women in clinical trials, improving data standards, and coordinating federal agencies — including HHS, Defense, Veterans Affairs, and the Office of Science and Technology Policy — to accelerate research and address disparities, particularly for women of color and women with disabilities. It also sought to build public‑private partnerships to spur innovation and deliver rapid, high‑impact recommendations for federal action.
Melania Trump’s newly announced Advancing Women’s Health to Improve Outcomes in All Phases of Life executive order follows a similar philosophical path, signaling continuity in the growing bipartisan recognition that women’s health research has been historically underfunded. Like her predecessor, Trump is calling for increased federal coordination, expanded research investment, and deeper collaboration with private‑sector innovators. But her initiative differs in its framing and priorities: Trump places strong emphasis on using “super intelligence” and advanced biotechnology to accelerate discoveries, and she outlines a specific set of Five Pillars focused on speeding therapeutics from lab to patient, ensuring affordability, and breaking cultural silence around women’s health. While Jill Biden’s initiative was housed within the Gender Policy Council and structured as a government‑wide research overhaul, Melania Trump’s effort is positioned as a First Lady‑driven policy agenda under the Be Best umbrella, with a more explicit focus on emerging technologies and rapid translation of treatments. Together, the two initiatives reflect a rare point of continuity between administrations — a shared acknowledgment that women’s health research requires urgent national attention and sustained federal leadership.
Presidential Support
President Trump attended the event and congratulated the First Lady for what he called an “outstanding contribution” to national health policy. “She’s a very skilled person,” he said, praising her leadership on issues ranging from technology to family support programs.
The administration says the initiative will help ensure American women have access to “the highest‑quality, scientifically supported medical information and care,” while accelerating the development of new treatments and cures.
A White House fact sheet detailing the executive order is available online.